Stryker Stock News

Kalamazoo, Michigan, March 24, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced its 2022 Annual Meeting of Shareholders is scheduled as follows:

Stryker is a well-established medical devices stock with appealing growth prospects.

According to Medtronic (MDT), Touch Surgery Enterprise is the first AI-powered platform of its kind for the operating room (OR). It is compatible with Medtronic's Hugo robotic-assisted surgery (RAS) s

Both are two exceptional growth stocks -- but which is the better choice for investors now?

Upgrades Bernstein upgraded the previous rating for Stryker Corp (NYSE:SYK) from Market Perform to Outperform. For the fourth quarter, Stryker had an EPS of $2.71, compared to year-ago quarter EPS of

Upgrades Bernstein upgraded the previous rating for Stryker Corp (NYSE: SYK ) from Market Perform to Outperform. For the fourth quarter, Stryker had an EPS of $2.71, compared to year-ago quarter EPS of $2.81. At the moment, the stock has a 52-week-high of $281.16 and a 52-week-low of $227.84. Stryker closed at $254.34 at the end of the last trading period. For Edwards Lifesciences Corp (NYSE: EW ), Bernstein upgraded the previous rating of Market Perform to Outperform. Edwards Lifesciences earned $0.51 in the fourth quarter, compared to $0.50 in the year-ago quarter. At the moment, the stock has a 52-week-high of $131.73 and a 52-week-low of $78.44. Edwards Lifesciences closed at $106.15 at the end of the last trading period. According to Morgan Stanley, the prior rating for KE Holdings Inc (NYSE: BEKE ) was changed from Equal-Weight to Overweight. KE Holdings earned $0.01 in the fourth quarter, compared to $0.26 in the year-ago quarter. At the moment, the stock has a 52-week-high of $72.49 and a 52-week-low of $7.31.

Stryker (NYSE:SYK) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 3 2 0 0 Last 30D 0 1 0 0

The post-Covid recovery in elective procedures is far from certain. But if it materializes, it could stoke some health care stocks.

We provide a summary of upcoming ex-dividend dates in a quick reference table.

Las Vegas, USA, March 08, 2022 (GLOBE NEWSWIRE) -- Surgical Robotic Systems Market to Grow at a Significant CAGR of 11.5% by 2026, as per DelveInsight''s Analysis The demand for Surgical Robotic Systems is witnessing a huge surge due to increasing surgical procedures which can be attributed to various factors such as increasing geriatric population who form a big part of the at-risk population for prostate cancer, valvular diseases, endometriosis among other diseases leading to a direct increase in the Surgical Robotic Systems Market. DelveInsight''s Surgical Robotic Systems Market Insights and Forecast report provides the current and forecast Surgical Robotic Systems Market, upcoming innovation in the devices, individual market shares, challenges, drivers, and barriers, market trends, and key competitors in the Surgical Robotic Systems Market. Some of the essential factors from the Surgical Robotic Systems Market report: As per DelveInsight analysis, in terms of revenue share, North America is predicted to register the fastest growth and occupy the largest Surgical Robots market share.

Stryker (SYK) continues to benefit from strength in the robotic-arm assisted surgery platform, Mako, and broad product portfolio. However, pricing pressure remains a concern.

Stryker (SYK) continues to benefit from strength in the robotic-arm assisted surgery platform, Mako, and broad product portfolio. However, pricing pressure remains a concern.

MedTech stocks like Medtronic (MDT), Stryker (SYK), Allscripts Healthcare Solutions (MDRX) and Syneos Health (SYNH) are evolving rapidly in the field of AI-driven technologies.